rs183860695
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001039213.4(CEACAM16):c.352G>A(p.Glu118Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00273 in 1,576,586 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 18 hom. )
Consequence
CEACAM16
NM_001039213.4 missense
NM_001039213.4 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 4.81
Genes affected
CEACAM16 (HGNC:31948): (CEA cell adhesion molecule 16, tectorial membrane component) The protein encoded by this gene is a secreted glycoprotein that in mouse interacts with tectorial membrane proteins in the inner ear. The encoded adhesion protein is found in cochlear outer hair cells and appears to be important for proper hearing over an extended frequency range. Defects in this gene likely are a cause of non-syndromic autosomal dominant hearing loss. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 19-44703663-G-A is Benign according to our data. Variant chr19-44703663-G-A is described in ClinVar as [Benign]. Clinvar id is 226506.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-44703663-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.352G>A | p.Glu118Lys | missense_variant | 3/7 | ENST00000587331.7 | NP_001034302.2 | |
CEACAM16 | XM_017026795.2 | c.352G>A | p.Glu118Lys | missense_variant | 2/5 | XP_016882284.1 | ||
CEACAM16-AS1 | NR_186815.1 | n.348-4486C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM16 | ENST00000587331.7 | c.352G>A | p.Glu118Lys | missense_variant | 3/7 | 1 | NM_001039213.4 | ENSP00000466561.1 |
Frequencies
GnomAD3 genomes AF: 0.00221 AC: 336AN: 152022Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
336
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00329 AC: 676AN: 205396Hom.: 3 AF XY: 0.00326 AC XY: 361AN XY: 110864
GnomAD3 exomes
AF:
AC:
676
AN:
205396
Hom.:
AF XY:
AC XY:
361
AN XY:
110864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00279 AC: 3972AN: 1424446Hom.: 18 Cov.: 32 AF XY: 0.00286 AC XY: 2015AN XY: 703432
GnomAD4 exome
AF:
AC:
3972
AN:
1424446
Hom.:
Cov.:
32
AF XY:
AC XY:
2015
AN XY:
703432
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00221 AC: 336AN: 152140Hom.: 2 Cov.: 32 AF XY: 0.00195 AC XY: 145AN XY: 74370
GnomAD4 genome
AF:
AC:
336
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
145
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
23
ExAC
AF:
AC:
294
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 16, 2015 | p.Glu118Lys in exon 3 of CEACAM16: This variant is not expected to have clinical significance because it has been identified in 0.5% (188/34916) of European chr omosomes including 1 homozygote by the Exome Aggregation Consortium (ExAC, http: //exac.broadinstitute.org; dbSNP rs183860695). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 17, 2017 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;N
REVEL
Benign
Sift
Benign
.;D
Sift4G
Uncertain
T;T
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at